Source: Medicines Authority (MT) Revision Year: 2023 Publisher: Medochemie Ltd, 1-10 Constantinoupoleos Street, 3011 Limassol, Cyprus
MEDAPIA 200mg film-coated tablets.
Pharmaceutical Form |
---|
Film-coated tablet. Brown, capsule-shaped, convex, film-coated tablets with dimension 19x10 mm. |
Each film-coated tablet of MEDAPIA contains 200mg entacapone.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Entacapone |
Entacapone belongs to a new therapeutic class, catechol-O-methyl transferase (COMT) inhibitors. It is a reversible, specific, and mainly peripherally acting COMT inhibitor designed for concomitant administration with levodopa preparations. Entacapone prolongs the clinical response to levodopa. |
List of Excipients |
---|
Core: Cellulose microcrystalline 102 Coating: Hypromellose 2910 5mPa•s E464 |
The tablets are packed in:
Not all pack sizes may be marketed.
Medochemie Ltd, 1-10 Constantinoupoleos Street, 3011 Limassol, Cyprus
MA032/13201
Date of first authorisation: 20th of April 2018
Date of renewal: 5th January 2023
Drug | Countries | |
---|---|---|
MEDAPIA | Spain, Lithuania, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.